5:38 PM
 | 
Apr 02, 2013
 |  BC Extra  |  Company News

Merz makes competing offer for Obagi

Merz GmbH & Co. KGaA (Frankfurt, Germany) made public on Tuesday an offer to acquire skin disorder company Obagi Medical Products Inc. (NASDAQ:OMPI) for $22 per share in cash, or about $383.6 million based on 17.4 million Obagi shares outstanding as...

Read the full 189 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >